Both in Pharmaceuticals

Pasithea Therapeutics vs Context Therapeutics

Over the past year KTTA returned −31.0% and CNTX returned −81.7%; their daily moves had a correlation of 0.06.

KTTA −31.0% CNTX −81.7%Growth of $1, one year, split-adjusted
MetricKTTACNTX
Price$0.5300$0.2035
Market cap$17.7M$18.7M
Today0.00%+4.90%
1 month+18.6%−36.8%
6 months−37.6%−91.6%
Year to date−58.9%−86.2%
1 year−35.0%−81.2%
Revenue growth (YoY)——
Gross margin——
Net margin——
P/E (TTM)——
Price / sales——
Net cash$45.7M$43.0M
Dividend yield——
Volatility (60d)103.5%70.0%
Short % of float0.5%6.2%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).

KTTA vs CNTX: Pasithea Therapeutics vs Context Therapeutics Stock Comparison | Gainbot